Wayland Group Corp. (MRRCF)

0.0000 0.0000 (0.00%) At close: 10:07AM EDT

Wayland Group Corp.

2381 Bristol Circle
Door D Suite 102
Oakville, ON L6H 5S9
Canada
289-288-6274
https://www.waylandgroup.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 68

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. David Miller	Chief Financial Officer	N/A	N/A	N/A
Dr. James Hyssen	Chief Operating Officer	N/A	N/A	N/A
Dr. Steven Prescott Bennett Ph.D.	Chief Scientific Officer	N/A	N/A	N/A
Shawn Alexander	Vice President of Investor Relations	N/A	N/A	N/A
Graham Farrell	Vice President of Communications	N/A	N/A	N/A
Mr. Geoff Kosar	Vice President of Sales & Marketing	N/A	N/A	N/A
Mr. Raymond Howrad Stone	Secretary	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. It offers a range of CBD, balanced, and THC strains under the Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann names. The company was founded in 2013 and is headquartered in Oakville, Canada. Wayland Group Corp. is a subsidiary of Maricann Group Inc.

Corporate Governance

Wayland Group Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.